Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

SR 103 MeSH Supplementary Concept Data 2025


MeSH Supplementary
SR 103
Unique ID
C113926
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C113926
Entry Term(s)
1,4-bis(guanidinoethylamino)-5,8-dihydroxyanthracene-9,10-dione dihydrochloride
SR-103
Pharm Action
Topoisomerase II Inhibitors
Registry Numbers
0
Heading Mapped to
*Anthraquinones
*Guanidines
Frequency
1
Note
structure in first source
Source
Anticancer Drug Des 1998 Jul;13(5):407-15
Date of Entry
1998/08/28
Revision Date
2015/08/18
SR 103 Preferred
1,4-bis(guanidinoethylamino)-5,8-dihydroxyanthracene-9,10-dione dihydrochloride Broader
page delivered in 0.004s